• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AGN 2.08% 70.5¢

ARGENICA THERAPEUTICS LIMITED

Argenica Therapeutics Limited is an Australia-based clinical drug development company.... Argenica Therapeutics Limited is an Australia-based clinical drug development company. The Company is focused on developing therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The Company's lead candidate, ARG-007, is a cationic arginine-rich peptide that aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury, in order to minimize the impact of these conditions and improve patient recovery. ARG-007 has been successfully demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischaemic encephalopathy (HIE). More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
AGN 22/05/24 5 2.3K
22/05/24 Last post  TradingHault Comments Created with Sketch.  5  Views Created with Sketch.  2.3K 
AGN 22/05/24 16 4.9K
22/05/24 Last post  rjmc Comments Created with Sketch.  16  Views Created with Sketch.  4.9K 
AGN 13/05/24 59 15K
13/05/24 Last post  Lefevre Comments Created with Sketch.  59  Views Created with Sketch.  15K 
AGN
AGN Media thread
2
13/05/24 82 25K
13/05/24 Last post  TradingHault Comments Created with Sketch.  82  Views Created with Sketch.  25K 
AGN 24/04/24 1 607
24/04/24 Last post  TradingHault Comments Created with Sketch.  1  Views Created with Sketch.  607 
AGN 22/04/24 6 1.2K
22/04/24 Last post  daveg Comments Created with Sketch.  6  Views Created with Sketch.  1.2K 
AGN 22/04/24 0 189
22/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  189 
AGN
News: AGN Argenica Therapeutics Successfully Completes A$12.0M Placement
12/04/24 0 252
12/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  252 

See All Discussions arrow Created with Sketch.

Timeline

ARG-007 Reduces Effects of TBI in Preclinical Study
15 May 08:25
 
DSMB Confirms Safety of First Patients Dosed
29 Apr 09:02
 
Quarterly Activities/Appendix 4C Cash Flow Report
24 Apr 08:47
 
Cleansing Notice
22 Apr 09:18
 
Application for quotation of securities - AGN
22 Apr 09:16
 
Proposed issue of securities - AGN
12 Apr 09:14
 
View More arrow Created with Sketch.
(20min delay)
Last
70.5¢
Change
-0.015(2.08%)
Mkt cap ! $86.58M
Open High Low Value Volume
72.0¢ 72.0¢ 70.0¢ $55.25K 77.46K

Buyers (Bids)

No. Vol. Price($)
3 16703 69.5¢
 

Sellers (Offers)

Price($) Vol. No.
71.0¢ 9898 2
View Market Depth
Last trade - 14.10pm 24/05/2024 (20 minute delay) ?
Last
69.5¢
  Change
-0.015 ( 2.80 %)
Open High Low Volume
70.0¢ 70.0¢ 69.5¢ 5477
Last updated 13.58pm 24/05/2024 ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.